1. Academic Validation
  2. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1

A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1

  • Nat Genet. 2007 Feb;39(2):207-11. doi: 10.1038/ng1954.
Jochen Hampe 1 Andre Franke Philip Rosenstiel Andreas Till Markus Teuber Klaus Huse Mario Albrecht Gabriele Mayr Francisco M De La Vega Jason Briggs Simone Günther Natalie J Prescott Clive M Onnie Robert Häsler Bence Sipos Ulrich R Fölsch Thomas Lengauer Matthias Platzer Christopher G Mathew Michael Krawczak Stefan Schreiber
Affiliations

Affiliation

  • 1 Institute for Clinical Molecular Biology, Christian-Albrechts University Kiel, University Hospital Schleswig-Holstein, 24105 Kiel, Germany. [email protected]
Abstract

We performed a genome-wide association study of 19,779 nonsynonymous SNPs in 735 individuals with Crohn disease and 368 controls. A total of 7,159 of these SNPs were informative. We followed up on all 72 SNPs with P <or= 0.01 with an allele-based disease association test in 380 independent Crohn disease trios, 498 Crohn disease singleton cases and 1,032 controls. Disease association of rs2241880 in the autophagy-related 16-like 1 gene (ATG16L1) was replicated in these samples (P = 4.0 x 10(-8)) and confirmed in a UK case-control sample (P = 0.0004). By haplotype and regression analysis, we found that marker rs2241880, a coding SNP (T300A), carries virtually all the disease risk exerted by the ATG16L1 locus. The ATG16L1 gene encodes a protein in the autophagosome pathway that processes intracellular bacteria. We found a statistically significant interaction with respect to Crohn disease risk between rs2241880 and the established CARD15 susceptibility variants (P = 0.039). Together with the lack of association between rs2241880 and ulcerative colitis (P > 0.4), these data suggest that the underlying biological process may be specific to Crohn disease.

Figures